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Anti-inﬂammatoryAbstract B-friedoolean-5-ene-3-b-ol (1), b-sitosterol (2), stigmasta-5,22,25-trien-3-b-ol (3),
betulinic acid (4), and 5-hydroxy-6,7,40-trimethoxyﬂavone (5) were isolated from the aerial parts
of Clerodendrum inerme L. (Verbenaceae). Their structures were established based on analyses of
physical and spectroscopic data. Compounds 1, 4, and 5 were isolated for the ﬁrst time from the
plant. C. inerme L. was known as a rich source of terpenes, sterols, and phenolic compounds, so
the antioxidant and anti-inﬂammatory activities were evaluated. The total methanolic extract
(TME) and compound 5 showed scavenging activity with maximum inhibition of 61.84% for
TME (100 lg/mL) and 37.19% for 5 (20 lM), respectively, using DPPH assay. In addition, the
TME exhibited anti-inﬂammatory activity more than indomethacin at dose 200 mg/kg using the
formalin induced hind paw edema method.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
The genus Clerodendrum (Family: Verbenaceae) is very widely
distributed in tropical and subtropical regions of the world.
More than ﬁve hundred species of the genus were identiﬁed.1
They include small trees, shrubs, and herbs.1 C. inerme is a
shrub distributed in South and South-east Asia, Australia,
and Paciﬁc islands. The plant is used in the treatment of scrof-
ulous and venereal infections, and also as an antidote for poi-
soning from ﬁsh, crabs, and toadstools.2 The fresh leaf juice is
166 S.R.M. Ibrahim et al.used externally for treating skin diseases. Moreover, the roots
are boiled in oil and used in rheumatic affections.3,4 The plant
had been shown to possess antimicrobial, anti-coagulants,
uterine stimulant, hypertensive, and laxative effects.3,4 Previ-
ous phytochemical studies of this plant lead to the isolation
of sterols,5,6 ﬂavones,7 clerodane diterpenes,8,9 neolignans,10
iridoid glycosides,11,12 and triterpenes.13 As part of our ongo-
ing study on Egyptian plants, we investigated the constituents
of C. inerme L. (Verbenaceae). The present study reports the
isolation and structural elucidation of ﬁve compounds:
B-friedoolean-5-ene-3-b-ol (1),14 b-sitosterol (2),15 stigmasta-
5,22,25-trien-3-b-ol (3),16,17 betulinic acid (4),18,19 and
5-hydroxy-6,7,40-trimethoxyﬂavone (5).20 The anti-inﬂamma-
tory activity of the TME at different doses using the formalin
induced hind paw edema method and indomethacin as stan-
dard was evaluated. Also, the TME and compound 5 were
tested for their antioxidant activity using DPPH assay com-
pared with propyl gallate (standard synthetic antioxidant).2. Experimental
2.1. General procedures
Melting points were carried out using an Electrothermal 9100
Digital Melting Point apparatus (Electrothermal Engineering
Ltd, Essex, England). The UV spectrum was determined using
a Perkin Elmer double beam spectrophotometer Model 550S,
attached to a Hitachi recorder Model 561, using a 1 cm quartz
cell. The IR spectra were measured on a Shimadzu Infrared-
400 spectrophotometer (Kyoto, Japan). EIMS were recorded
on a Finnigan MAT TSQ 7000 mass spectrometer. 1D and
2D NMR spectra (chemical shifts in ppm, coupling constants
in Hz) were recorded on a Bruker BioSpin GmbH 400 MHz
Ultrashield spectrometer using CDCl3 as solvent, with TMS
as the internal reference. Solvents were distilled prior to spec-
troscopic measurements. Column chromatographic separa-
tions were performed on SiO2 60 (0.04–0.063 mm, Merck).
TLC was performed on pre-coated TLC plates with SiO2 60
F254 (0.2 mm, Merck). The solvent systems used for TLC anal-
yses were n-hexane:EtOAc (90:10, S1), n-hexane:EtOAc (85:15,
S2), and CHCl3:MeOH (95:5, S3). The compounds were
detected by UV absorption at kmax 255 and 366 nm followed
by spraying with anisaldehyde:H2SO4 reagent and heating at
110 C for 1–2 min.
2.2. Plant material
Clerodendron inerme L. aerial parts were collected in March
2009 from the botanical garden, Faculty of Agriculture, Assiut
University and were authenticated by Dr. Abdulaziz. A.
Fayed, Prof. of Plant Taxonomy, Faculty of Science, Assiut
University, Assiut, Egypt. A voucher specimen was deposited
at the Department of Pharmacognosy, Faculty of Pharmacy,
Minia University, Minia, Egypt (Registration code CIS-2009).
2.3. Extraction and isolation
The air-dried powdered aerial parts of C. inerme (400 g) were
extracted with 70% MeOH (4 · 1.5 L) at room temperature.
The combined methanol extract was concentrated underreduced pressure to afford a dark green residue (27.5 g). The
TME (2.5 g) was kept for biological study. The TME
(25.0 g) was subjected to vacuum liquid chromatography
(VLC) using n-hexane:EtOAc and EtOAc:MeOH gradients
to afford six fractions: CI-1 (5.4 g; n-hexane, 100%), CI-2
(3.4 g; n-hexane:CHCl3, 50:50), CI-3 (3.1 g; CHCl3, 100%),
CI-4 (2.9 g; CHCl3:EtOAc, 50:50), CI-5 (2.1 g; EtOAc,
100%), and CI-6 (6.5 g; MeOH, 100%). CI-2 (3.4 g) was sub-
jected to SiO2 column chromatography (160 g · 50 cm · 2 cm)
using n-hexane:EtOAc gradient to afford compounds 1
(8.7 mg, white crystals) and 2 (11.2 mg, colorless needles).
Fraction CI-3 (3.1 g) was chromatographed over SiO2 column
(140 g · 50 cm · 2 cm) using n-hexane:EtOAc gradient to
obtain compounds 3 (5.4 mg, colorless needles) and 4
(5.6 mg, colorless needles). SiO2 column chromatography
(120 g · 50 cm · 2 cm) of fraction CI-4 (2.9 g) using n-hex-
ane:EtOAc as an eluent gave 5 (14 mg, yellow crystals). Other
fractions were kept for further investigations.
D:B-friedoolean-5-ene-3-b-ol (1): It was obtained as white
crystals (8.7 mg, MeOH); Rf 0.79 (S1). m.p. 211–212 C. EIMS:
m/z 426 [M]+. IR (KBr): cmax 3440, 2890, 1040 cm
1. 1H
NMR (CDCl3, 400 MHz): dH 1.48 (2H, m, H-1), 1.85 (1H,
m, H-2A), 1.72 (1H, m, H-2B), 3.48 (1H, t, J= 2.9 Hz,
H-3), 5.64 (1H, d, J= 6.0 Hz, H-6), 2.02 (1H, m, H-7A),
1.68 (1H, m, H-7B), 1.55 (1H, m, H-8), 0.90 (1H, m, H-10),
1.38 (2H, m, H-11), 1.35 (1H, m, H-12A), 1.27 (1H, m,
H-12B), 1.52 (1H, m, H-15A), 0.93 (1H, m, H-15B), 1.40
(1H, m, H-16A), 1.23 (1H, m, H-16B), 1.59 (1H, m, H-18),
1.53 (2H, m, H-19), 1.60 (2H, m, H-21), 1.39 (2H, m, H-22),
1.04 (3H, s, H-23), 1.14 (3H, s, H-24), 0.85 (3H, s, H-25),
1.09 (3H, s, H-26), 1.00 (3H, s, H-27), 1.16 (3H, s, H-28),
0.95 (3H, s, H-29), 0.99 (3H, s, H-30). 13C NMR (CDCl3,
100 MHz): dC 18.2 (C-1), 27.8 (C-2), 76.5 (C-3), 40.5 (C-4),
141.8 (C-5), 122.5 (C-6), 23.5 (C-7), 47.5 (C-8), 34.6 (C-9),
50.1 (C-10), 34.4 (C-11), 30.5 (C-12), 39.3 (C-13), 37.8
(C-14), 32.0 (C-15), 36.0 (C-16), 30.1 (C-17), 43.2 (C-18),
35.0 (C-19), 28.5 (C-20), 33.2 (C-21), 38.9 (C-22), 28.5
(C-23), 25.6 (C-24), 16.2 (C-25), 19.5 (C-26), 18.4 (C-27),
32.2 (C-28), 34.6 (C-29), 32.2 (C-30).14
b-Sitosterol (2): It was isolated as colorless needles
(11.2 mg, acetone); Rf = 0.73 (S1). m.p. 139–140 C. IR
(KBr): cmax 3455, 2940, 1617, 1454, 1385, 1062 cm
1. EIMS:
m/z 414 [M]+. NMR data (400 and 100 MHz, CDCl3) are in
good agreement with the published data.15
Stigmasta-5,22,25-trien-3-b-ol (3): It was obtained as color-
less needles (5.4 mg, acetone); Rf 0.61 (S1). m.p. 158–160 C.
IR (KBr): cmax 3340, 2940, 1640, 1060 cm
1. EIMS: m/z 410
[M]+. 1H NMR (CDCl3, 400 MHz): dH 1.80 (1H, m, H-1A),
1.10 (1H, m, H-1B), 1.79 (1H, m, H-2A), 1.36 (1H, m,
H-2B), 3.55 (1H, m, H-3), 1.70 (1H, m, H-4A), 1.26 (1H, m,
H-4B), 5.35 (1H, d, J= 5.0 Hz, H-6), 1.62 (1H, m, H-7A),
1.28 (1H, m, H-7B), 1.55 (1H, m, H-8), 1.65 (1H, m, H-9),
1.72 (1H, m, H-11A), 1.49 (1H, m, H-11B), 2.04 (2H, m,
H-12), 1.80 (1H, m, H-14), 1.52 (1H, m, H-15A), 1.40 (1H,
m, H-15B), 1.66 (1H, m, H-16A), 1.25 (1H, m, H-16B), 1.24
(1H, m, H-17), 0.55 (3H, s, H-18), 0.80 (3H, s, H-19), 2.01
(1H, m, H-20), 1.02 (3H, d, J= 6.5 Hz, H-21), 5.25 (1H, dd,
J= 15.5, 7.8 Hz, H-22), 5.21 (1H, dd, J= 15.5, 7.8 Hz,
H-23), 2.42 (1H, m, H-24), 1.65 (3H, s, H-26), 4.69 (1H, s,
H-27A), 4.67 (1H, s, H-27B), 0.84 (3H, t, J= 7.5 Hz, H-29).
13C NMR (CDCl3, 100 MHz): dC 37.2 (C-1), 38.1 (C-2), 71.1
(C-3), 39.5 (C-4), 140.7 (C-5), 121.6 (C-6), 31.6 (C-7), 40.5
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(C-13), 55.1 (C-14), 23.0 (C-15), 28.5 (C-16), 55.9 (C-17),
12.0 (C-18), 13.1 (C-19), 40.3 (C-20), 20.9 (C-21), 138.3
(C-22), 129.2 (C-23), 52.1 (C-24), 148.5 (C-25), 20.2 (C-26),
109.5 (C-27), 25.6 (C-28), 12.2 (C-29).16,17
Betulinic acid (4): It was obtained as colorless needles
(5.6 mg, acetone); Rf 0.41 (S2), m.p. 292–293 C. EIMS: m/z
456 [M]+. 1H NMR (CDCl3, 400 MHz): dH 1.19 (2H, m, H-
1), 1.56 (2H, m, H-2), 3.19 (1H, m, H-3), 0.65 (1H, m, H-5),
1.42 (2H, m, H-6), 1.47 (2H, m, H-7), 1.25 (1H, m, H-9), 1.23
(2H, m, H-11), 1.68 (1H, m, H-12A), 1.30 (1H, m, H-12B),
2.20 (1H, dd, J= 9.5, 3.6, H-13), 2.27 (1H, m, H-15A), 1.54
(1H, m, H-15B), 2.37 (1H, m, H-16A), 1.50 (1H, m, H-16B),
1.61 (1H, m, H-18), 3.01 (1H, dt, J= 8.5, 4.0 Hz, H-19), 1.96
(1H, m, H-21A), 1.42 (1H, m, H-21B), 1.97 (2H, m, H-22),
0.96 (3H, s, H-23), 0.75 (3H, s, H-24), 0.82 (3H, s, H-25),
0.93 (3H, s, H-26), 0.97 (3H, s, H-27), 4.74 (1H, s, H-29A),
4.51 (1H, s, H-29B), 1.69 (3H, s, H-30). 13C NMR (CDCl3,
100 MHz): dC 38.7 (C-1), 27.4 (C-2), 78.9 (C-3), 38.8 (C-4),
55.3 (C-5), 18.2 (C-6), 34.3 (C-7), 40.7 (C-8), 50.5 (C-9), 37.2
(C-10), 20.8 (C-11), 25.5 (C-12), 38.3 (C-13), 42.4 (C-14), 30.5
(C-15), 32.1 (C-16), 56.3 (C-17), 46.9 (C-18), 49.2 (C-19),
150.4 (C-20), 29.7 (C-21), 37.0 (C-22), 28.0 (C-23), 15.3
(C-24), 16.0 (C-25), 16.1 (C-26), 14.7 (C-27), 180.1 (C-28),
110.0 (C-29), 19.3 (C-30).18,19HO
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Figure 1 Structures of the5-Hydroxy-6,7,40-trimethoxyﬂavone (5): It was obtained as
yellow crystals (14 mg, MeOH); Rf 0.69 (S3). m.p. 189–190 C.
UV (MeOH): kmax 272, 335. EIMS: m/z 328 [M]
+. 1H NMR
(CDCl3, 400 MHz): dH 6.58 (1H, s, H-3), 6.54 (1H, s, H-8),
7.83 (1H, d, J= 7.2 Hz, H-20), 7.01 (1H, d, J= 7.2 Hz, H-
30), 7.01 (1H, d, J= 7.2 Hz, H-50), 7.83 (1H, d, J= 7.2 Hz,
H-60), 12.77 (1H, s, 5-OH), 3.93 (3H, s, 6-OCH3), 3.96 (3H,
s, 7-OCH3), 3.89 (3H, s, 4
0-OCH3).
13C NMR (CDCl3,
100 MHz): dC 164.0 (C-2), 104.1 (C-3), 182.7 (C-4), 153.0
(C-5), 132.6 (C-6), 158.7 (C-7), 90.5 (C-8), 153.2 (C-9), 106.1
(C-10), 123.5 (C-10), 128.0 (C-20), 114.5 (C-30), 162.6 (C-40),
114.5 (C-50), 128.0 (C-60), 60.8 (6-OCH3), 56.3 (7-OCH3),
55.5 (40-OCH3).
202.4. Antioxidant activity
The antioxidant activity was evaluated using 2,20-diph-
enylpicrylhydrazyl (DPPH) assay as previously outlined.21
1 mL of the TME (25, 50, and 100 lg/mL) and compound 5
(20 lM) were mixed with 1 mL of DPPH (4 mg was dissolved
in 50 mL HPLC MeOH to obtain a concentration of 80 lg/
mL) and allowed to stand for half an hour for any reaction
to occur. The UV absorbance was recorded at 517 nm com-
pared to DPPH in MeOH (blank). The experiment wasO
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Table 1 The DPPH radical scavenging activity results.
Sample Conc. DPPH (% inhibition)
TME* 25 29.71
50 47.24
100 61.84
5** 20 37.19
Values are mean of 3 experimental.
* Conc. (lg/mL).
** Conc. (lM).
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.2.5. Pharmacological study
2.5.1. Animals
Adult male albino rats (100–120 g) were used. The animals
were housed under standardized environmental conditions in
the pre-clinical Animal House, Pharmacology Department,
Faculty of Medicine, Assuit University, Assiut, Egypt. The
animals were fed with standard diet and free access to water.
They were kept at 24–28 C temperature, 60–70% relative
humidity, and light/dark cycle (12 h:12 h) for one week to
acclimatize to environmental conditions. The work was con-
ducted in accordance with the internationally accepted princi-
ples for laboratory animals’ use and care as found in the
European Community Guidelines, and approval of the Institu-
tional Ethics Committee was obtained.22
2.5.2. Anti-inﬂammatory activity
Hind paw edema was induced by injection of 4% formalin
(20 lL) solution into the subplanter region of the left hind
paw of adult male albino rats (100–120 g).23 The inﬂamed ani-
mals were divided randomly into ﬁve groups (6 for each):
inﬂamed control group, inﬂamed treated with indomethacin
(at a dose of 8 mg/kg subcutaneously), three groups of
inﬂamed animals were treated with the TME individually at
doses of 50, 100, and 200 mg/kg subcutaneously (the plant
extract was dissolved in sterile distilled water). The change in
paw thickness in all tested animals was measured with Plethys-
mometer 7150 (UGO, Basil, Italy) at 0, 1, 2, 4, and 6 h after
formalin solution injection. The anti-inﬂammatory effect of
the tested extract was calculated in comparison to inﬂamed
control group as shown in Table 2. The percentage of edema
(inﬂammation) was calculated according to the following
equation:24
Inhibitionð%Þ ¼ Vc  Vt
Vc
 100
Vc = Volume of paw edema in control animals.
Vt = Volume of paw edema in treated animals.
Chemical constituents and biological investigations of Clerodendrum inerme 1692.6. Statistical analysis
All data were expressed as mean ± standard error using
Student’s t test and the statistical signiﬁcance was evaluated
by a one-way analysis of variance (ANOVA). The values were
considered to be signiﬁcantly different when P values were less
than 0.01.
3. Discussion and conclusion
Two sterols (2 and 3), two triterpene derivatives (1 and 4), and
a methoxylated ﬂavonoid (5) were isolated from the MeOH
extract of C. inerme L. aerial parts cultivated in Egypt
(Fig. 1). Compounds 1, 4, and 5 have been isolated for the ﬁrst
time from the plant under investigation. Their structures were
established by physical and spectral data (UV, 1D, 2D NMR,
and MS), as well as comparison with authentic samples and
the literature.
The TME and 5 showed a concentration dependent scaveng-
ing activity by quenching DPPH radical (Table 1), maximum
inhibition (61.84% for TME at 100 lg/mL and 37.19 for 5 at
20 lM) of DPPH. This antioxidant capacity of the TME may
be due to its phenolic contents. Furthermore, the TME of the
plant was tested for its anti-inﬂammatory effect using formalin
induced hind paw edema test. It is well known that inhibition of
formalin induced paw edema in rats is one of the most suitable
test procedures to screen anti-arthritic and anti-inﬂammatory
agents as it closely resembles human arthritis. Injection of for-
malin subcutaneously into hind paw of rats produced localized
inﬂammation and pain. The nociceptive effect of formalin is
biphasic. The earlier phase of formalin induced pain reﬂects
the direct effect of formalin on nociceptors, whereas the late
phase reﬂects inﬂammatory pain which appears to be attribut-
able to prostaglandin synthesis.25,26 Inﬂammatory disorders are
also accompanied by the production of signiﬁcant amounts of
free radicals and nitrogen reactive species.27 The TME extract
of C. inerme showed anti-inﬂammatory activity more than
indomethacin at dose 200 mg/kg after 4 h (Table 2). That
may be due to the presence of ﬂavonoids, terpenes, and sterols
and also due to inhibition of main inﬂammatory mediators like
histamine, serotonin, prostaglandins, bradykinin, angiotensin,
tachykinin, platelet activating factor, and substance-P.28 Our
results show that C. inerme exerts signiﬁcant inhibitory effects
on nociceptive response of the late phase of the chemical and
inﬂammatory pain model in formalin test. The presence of
ﬂavonoids in C. inerme may modify the action or production
of free radicals and nitrogen reactive species.27 Also, the ﬂavo-
noids are known to inhibit the prostaglandin synthase enzyme,
specially the endoperoxide and reported to produce anti-
inﬂammatory activity (Table 2).29,30
4. Conﬂict of interest
None.
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